Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series

Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series

Abstract Background The expression of vascular endothelial growth factor (VEGF)-A/ VAGF receptors (VEGFRs) signaling plays a pivotal role in the tumor angiogenesis and the development of the immunosuppressive tumor microenvironment in glioblastomas. We have previously conducted exploratory clinical...

Full description

Bibliographic Details
Main Authors: Ryota Tamura, Yukina Morimoto, Kenzo Kosugi, Mizuto Sato, Yumiko Oishi, Ryo Ueda, Ryogo Kikuchi, Hideaki Nagashima, Shinobu Noji, Yutaka Kawakami, Hikaru Sasaki, Kazunari Yoshida, Masahiro Toda
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Cancer
Subjects:
VEGFR
Peptide vaccine
Glioblastoma
Bevacizumab
Online Access:http://link.springer.com/article/10.1186/s12885-020-6589-x

Internet

http://link.springer.com/article/10.1186/s12885-020-6589-x

Similar Items